PATENT CLAIM ANALYSIS

Application Number: 16156906
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "205100"]

Abstract:
This invention provides antibodies or fragments thereof that are capable of specifically binding to at least one conformational epitope of Human  Enterovirus  71 (EV71), wherein the antibody individually comprises at least one variable light chain and at least one variable heavy chain. There is also provided a method of producing an antibody capable of specifically binding to at least one conformational epitope of Human  Enterovirus  71 (EV71).

Claim (Index 7):
A method of treating at least one of an EV71-infection and at least one EV-linked disease selected from the group consisting of aseptic meningitis, encephalitis, cranial nerve palsies, Guillain-Barre syndrome, poliomyelitis-like syndrome, brainstem encephalitis, herpangina, and Hand, Foot and Mouth disease, the method comprising administering to a subject the antibody or epitope-binding fragment thereof of  claim 1 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.64444
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15104953', '14233719', '13185157', '12509835', '12483543']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6778878541967721
- 35 USC 102 Novelty (BERT): 0.680209872064165
- Combined Prediction Score: 0.6781200559835114
- Mean Citation Score: 368.01029000000005
- Max Citation Score: 669.0919
- Similarity Product: 664.2621531899453

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test